Zacks Research Cuts Earnings Estimates for Gilead Sciences
Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) – Stock analysts at Zacks Research reduced their Q3 2026 earnings per share estimates for shares of Gilead Sciences in a research report issued on Tuesday, February 25th. Zacks Research analyst E. Bagri now forecasts that the biopharmaceutical company will earn $2.20 per share for the quarter, down […]
Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) – Stock analysts at Zacks Research reduced their Q3 2026 earnings per share estimates for shares of Gilead Sciences in a research report issued on Tuesday, February 25th. Zacks Research analyst E. Bagri now forecasts that the biopharmaceutical company will earn $2.20 per share for the quarter, down […]
